Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Leyes y legislación
22
Patentes de invención
22
Propiedad industrial
15
Patentes
11
Derechos de autor
8
Marcas de fábrica
5
Historia
4
México
3
Transferencia de tecnología
3
Aspectos ambientales
2
Biotecnología
2
Biotecnología agrícola
2
Ciencia
2
Criptografía
2
Genes
2
Ingeniería genética
2
Literatura española
2
Marcas
2
Monopolios
2
PATENTES
2
PATENTS
2
Patents
2
Propiedad intelectual
2
Universidades
2
ACADEMIC PRODUCTION
1
ACADEMIC WOMEN
1
ANÁLISIS BIBLIOMÉTRICO
1
Acuerdos (Derecho)
1
Administración pública
1
Agricultura
1
-
401“…Patent ductus arteriosus (PDA), one of the most common congenital heart defects, is an abnormal persistence of a patent lumen in the arterial duct due to an arrest of the natural process of closure after it has served its function as a vital channel in fetal circulation. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
402por Manson, Ania L., Juneja, Rohit, Self, Robert, Farquhar-Smith, Paul, MacNeill, Fiona, Seneviratne, Suranjith L.“…Blue dyes such as Patent Blue V (PBV) have been used in medical procedures for decades, and in the United Kingdom they are routinely utilised in sentinel lymph node biopsy (SLNB) for staging the axilla in early breast cancer. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
403
-
404“…With new technologies, concerns about gene patent claims regarding isolated DNA are becoming less relevant, but broad method claims could be more problematic.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
405“…In this study we evaluated the presence of patent foramen ovale (PFO) in a cohort of 25 consecutive patients suffering from migraine with aura (MA) during an attack presenting to the emergency ward of an Italian hospital. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
406por Li, Weizhong, Kondratowicz, Bartosz, McWilliam, Hamish, Nauche, Stephane, Lopez, Rodrigo“…The non-redundant (NR) patent sequence databases comprise two-level nucleotide and protein sequence clusters (NRNL1, NRNL2, NRPL1 and NRPL2) based on sequence identity (level-1) and patent family (level-2). …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
407
-
408“…This study was aimed to determine the therapeutic principle and identify Chinese Patent Medicine (CPM) with corresponding indications for hypertension treatment. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
409“…The scope and eligibility of patents for genetic sequences have been debated for decades, but a critical case regarding gene patents (Association of Molecular Pathologists v. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
410
-
411por Cucoranu, Ioan C., Parwani, Anil V., Vepa, Suryanarayana, Weinstein, Ronald S., Pantanowitz, Liron“…Inventors of technology in this field typically file for patents to protect their intellectual property. An understanding of the patent landscape is crucial for companies wishing to secure patent protection and market dominance for their products. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
412
-
413por Meier, Bernhard“…Proof that percutaneous closure of the patent foramen ovale (PFO) is superior to medical treatment is still incomplete. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
414
-
415“…The importance of patents in a domain, the recency of patents in a domain and the immediacy of patents in a domain are all strongly correlated with increases in the rate of performance improvement in the domain of interest. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
416“…We analyze the patent filing strategies of foreign pharmaceutical companies in Chile distinguishing between “primary” (active ingredient) and “secondary” patents (patents on modified compounds, formulations, dosages, particular medical uses, etc.). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
417“…BACKGROUND: To achieve health development goals, policymakers are increasingly focused on improving primary care in low- and middle-income countries, and private sector drug retailers offer one channel through which basic services may be delivered. In Nigeria, patent and proprietary medicine vendors (PPMVs) serve as a main source of medications, but little is known about their clientele or how care is sought at PPMVs for common illnesses. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
418por Southan, Christopher“…Bioactive structures published in medicinal chemistry patents typically exceed those in papers by at least twofold and may precede them by several years. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
419por den Exter, AndréEnlace del recurso
Publicado 2016
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
420por Beall, Reed F., Schwalm, Jon-David R., Huffman, Mark D., McCready, Tara, Yusuf, Salim, Attaran, Amir“…We designated the United States and Canada as the base jurisdictions for this patent study. We linked patent data from these countries’ national medicine patent registers to patent information in over 96 other countries using Derwent and INPADOC via Thomson Innovation. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto